From The Lancet Psychiatry–In a setting with high risk of death in the first 4 weeks of opioid substitution therapy,buprenorphine seemed to reduce mortality in this period, but microscopic dissimilarity between buprenorphine and methadone was noted thereafter or for []The post Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study appeared first on Providers’ Clinical Support System For Opioid Therapies.
Source: pcss-o.org